SAN DIEGO, June 26, 2012 /PRNewswire/ — Medical Marijuana Inc., (OTC: MJNA) a leading hemp industry innovator, is pleased to update its shareholders on the status of its portfolio company, Red Dice Holdings and the Dixie family of products.
Recently, the Company acquired the licensing rights to the Dixie Elixirs brand through its portfolio company Red Dice Holdings, a company designed to license and market Dixie’s family of products. Medical Marijuana Inc., owns 60% of Red Dice Holdings.
Dixie Elixirs (www.dixieelixirs.com) is a Denver-based firm which specializes in the production and distribution of food, beverages and other products infused with medicinal cannabis. Dixie Elixirs has been highly successful in providing health and wellness products to the Colorado marketplace for the past 3 years. Recently, Dixie launched “Dixie X”, which is a new line of non-THC Hemp-based Cannabidiol (CBD) infused products.
The Dixie Elixirs and Edibles family of products consist of eight distinct and carefully formulated product lines of well over fifty five unique medicinal hemp infused products. This product portfolio includes medicated beverages and tonics, hemp capsules, medicated lozenges and edibles, as well as a full line of topicals and salves as part of the Dixie botanicals line of products which was recently featured on National Geographic’s series American Weed.
As one of the worlds most recognized medicinal hemp brands, the Dixie products are available throughout Colorado at over 450 licensed locations, where medical cannabis products are sold. Dixie focuses on the development of innovative and socially acceptable products and continues to develop or acquire new products to expand their overall portfolio.
Current Dixie medical cannabis based products:
Dixie Elixirs –
Medicated flavorful beverages
Dixie Chills –
Medicated ice cream
Dixie Edibles –
Dixie Botanicals –
Medicated topical applications
Dixie Scrips –
Medicated Capsules-form: Morning, Afternoon and Sleep formulas
Dixie Tonics –
Medicated energy shots
Dixie Dew Drops –
Current CBD-based products:
Dixie X Dew Drops
CBD-infused tinctures in a dropper bottle
Dixie X Scrips
CBD-infused pill form
Dixie X Botanicals
CBD-infused topicals, including salve
CanChew Chewing Gum
CBD-infused chewing gum providing an excellent delivery method for health and wellness
Within 60 days, Red Dice Holdings will launch on-line sales of the CBD based Dixie X and CanChew products in the US through licensed distribution companies. Selected international distribution will follow later this year. Hemp-based CBD products are legal in the United States and studies have shown them to be effective in treating a variety of medical conditions including pain management, anxiety, nausea and convulsions. The CBD health and wellness industry is estimated to be a $5 billion market.
For more information regarding CBD-infused products, see the following article:
MMJ CBD Infused Products Article
Within 90 days, Red Dice Holdings will enter into exclusive agreements to license the Dixie Elixirs brand, formulations, proprietary extraction processes, delivery methods, equipment and other intellectual property to carefully selected distribution partners in California, Arizona and Washington D.C. The agreements will include all of the Dixie products including Dixie X and CanChew gum.
According to the published See Change Strategy report, the medical cannabis industry is estimated to be a $1.7 billion market in 2012. Colorado, California and Arizona are estimated to account for 93% or approximately $1.6 billion. Red Dice Holdings will expand the Dixie brand throughout the remaining states and countries where medical cannabis is legal by continuing to develop exclusive licensing agreements.
To support the expansion initiatives, MJNA will launch a major marketing and public awareness campaign within the next 60 days to promote the Dixie and CanChew portfolio of products.
Recent MJNA Press Releases Regarding Dixie Elixirs:
Recent MJNA Press Releases Regarding CanChew Chewing Gum:
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor Relations Contact:
Stuart T. Smith
Email: [email protected]
SOURCE Medical Marijuana Inc.